FrancophonIA/ELRC3.0 huggingface dataset:
English: These medicines control human immunodeficiency virus (HIV) infection by stopping production of a protein that HIV needs for its multiplication.
Croatian: Ti lijekovi kontroliraju infekciju virusom humane imunodeficijencije (HIV) tako što zaustavljaju proizvodnju proteina koji je HIV-u potreban za umnažanje.
English: An alternate (non-hormonal) reliable method of contraception is recommended.
Croatian: Preporučuje se neka druga pouzdana (nehormonska) metoda kontracepcije.
English: It does this by slowing down the breakdown of atazanavir which will make it stay in the body for longer.
Croatian: To čini tako što usporava razgradnju atazanavira, zbog čega se on dulje zadržava u tijelu.
English: In the majority of cases, jaundice was reported within a few days to a few months after the initiation of treatment (see section 4.4).
Croatian: U većini je slučajeva žutica prijavljena unutar nekoliko dana do nekoliko mjeseci nakon početka liječenja (vidjeti dio 4.4).
English: When treating HIV infection, it is not always easy to identify what side effects are caused by EVOTAZ, by the other medicines you are taking, or by the HIV infection itself.
Croatian: Kod liječenja HIV infekcije, nije uvijek lako utvrditi koje su nuspojave izazvane lijekom EVOTAZ, koje drugim lijekovima koje uzimate, a koje samom HIV infekcijom.
English: What you need to know before you take EVOTAZ
Croatian: Što morate znati prije nego počnete uzimati EVOTAZ
English: It should be kept in mind that the twice weekly dosage of 150 mg may not provide an optimal exposure to rifabutin thus leading to a risk of rifamycin resistance and a treatment failure.
Croatian: Treba imati na umu da primjena doze od 150 mg dvaput tjedno možda neće osigurati optimalnu izloženost rifabutinu, što bi moglo dovesti do rizika od razvoja rezistencije na rifampicin i neuspješnog liječenja.
English: 90 (3 bottles of 30) film-coated tablets.
Croatian: 90 (3 boce s 30) filmom obloženih tableta.
English: SEDATIVES/HYPNOTICS Midazolam
Croatian: SEDATIVI/HIPNOTICI Midazolam
English: EVOTAZ may affect how well your kidneys work.
Croatian: EVOTAZ može utjecati na to kako dobro rade vaši bubrezi.
English: Consideration should be given to official guidance on the appropriate treatment of tuberculosis in HIV infected patients.
Croatian: U obzir treba uzeti službene smjernice o primjerenom liječenju tuberkuloze u bolesnika s HIV infekcijom.
English: Make sure your doctor knows: if you have liver problems if you develop signs or symptoms of gall stones (pain in your right side).
Croatian: Obavezno recite svom liječniku: ako imate jetrene tegobe. ako razvijete znakove ili simptome žučnih kamenaca ( bol na Vašoj desnoj strani).
English: Atorvastatin 10 mg single dose
Croatian: Atorvastatin 10 mg u jednokratnoj dozi
English: If co-administration is required, the daily dose of ketoconazole or itraconazole should not exceed 200 mg.
Croatian: Ako je istodobna primjena neophodna, dnevna doza ketokonazola ili itrakonazola ne smije biti veća od 200 mg.
English: Table 1: Interactions between EVOTAZ and other medicinal products Medicinal products by therapeutic area
Croatian: Tablica 1: Interakcije između lijeka EVOTAZ i drugih lijekova Lijekovi prema terapijskom području
English: The signs may be a mild yellowing of the skin or eyes.
Croatian: Znakovi mogu biti blago žuta boja kože ili bjeloočnica.
English: A long-term carcinogenicity study in mice did not show any carcinogenic potential.
Croatian: Dugoročno ispitivanje kancerogenosti u miševa nije pokazalo nikakav kancerogeni potencijal.
English: Any inflammatory symptoms should be evaluated and treatment instituted when necessary.
Croatian: . Svaki upalni simptom treba procijeniti i po potrebi liječiti.
English: Autoimmune disorders may occur many months after the start of treatment.
Croatian: Autoimune bolesti mogu nastupiti i više mjeseci nakon početka liječenja.
English: If you accidentally take more EVOTAZ than your doctor recommended, contact your doctor at once or contact the nearest hospital for advice.
Croatian: Ako slučajno uzmete više EVOTAZ tableta nego što Vam je liječnik preporučio, odmah se obratite liječniku ili potražite savjet u najbližoj bolnici
English: EVOTAZ is not a cure for HIV infection.
Croatian: EVOTAZ neće izliječiti HIV infekciju.
English: EVOTAZ may be used by adults aged 18 years of age and older who are infected with HIV, the virus that causes acquired immunodeficiency syndrome (AIDS).
Croatian: EVOTAZ mogu koristiti odrasle osobe u dobi od 18 ili više godina koje su zaražene HIV-om, virusom koji uzrokuje sindrom stečene imunodeficijencije (SIDA).
English: Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations.
Croatian: Farmakoterapijska skupina: Antivirotici za sistemsku primjenu; antivirotici za liječenje HIV-infekcije, kombinacije.
English: EVOTAZ should be administered 2 hours before or 1 hour after antacids or buffered medicinal products.
Croatian: EVOTAZ treba primijeniti 2 sata prije ili 1 sat nakon antacida ili puferiranih lijekova.
English: The following pack sizes are available: outer cartons containing 1 bottle of 30 film-coated tablets and outer cartons containing 90 (3 bottles of 30) film-coated tablets.
Croatian: Dostupne su sljedeće veličine pakiranja: kutija s 1 bocom koja sadrži 30 filmom obloženih tableta i kutija koja sadrži 90 (3 boce s 30) filmom obloženih tableta.
English: If the patient has developed SJS or DRESS associated with the use of EVOTAZ, EVOTAZ may not be restarted.
Croatian: Ako je bolesnik razvio SJS ili DRESS povezan s primjenom lijeka EVOTAZ, EVOTAZ se možda neće ponovno uvesti u terapiju.
English: Additional minor metabolic pathways consist of N-dealkylation and hydrolysis.
Croatian: Dodatni sporedni metabolički putovi sastoje se od N-dealkilacije i hidrolize.
English: Talk to your doctor about breast-feeding if you are taking EVOTAZ.
Croatian: Razgovarajte sa svojim liječnikom o dojenju ako uzimate EVOTAZ.
English: When co-administration is necessary, do not exceed 10 mg rosuvastatin daily, and clinical monitoring for safety (e.g. myopathy) is recommended.
Croatian: Kada je istodobna primjena neophodna, ne smije prelaziti 10 mg rosuvastatina dnevno i preporučuje se kliničko praćenje zbog sigurnosti (npr. miopatija).
English: PULMONARY ARTERIAL HYPERTENSION
Croatian: PLUĆNA ARTERIJSKA HIPERTENZIJA
English: Buspirone Clorazepate Diazepam Estazolam Flurazepam Zolpidem
Croatian: Buspiron Klorazepat Diazepam Estazolam Flurazepam Zolpidem
English: If the combination is needed, the recommended dose of rifabutin is 150 mg 3 times per week on set days (for example Monday-Wednesday-Friday).
Croatian: Ako je ta kombinacija neophodna, preporučena doza rifabutina je 150 mg triput tjedno u određene dane (na primjer, ponedjeljak-srijeda-petak).
English: Adverse reactions are listed by system organ class and frequency: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100) and rare (≥1/10,000 to 1/1,000).
Croatian: Nuspojave su prikazane prema organskom sustavu i učestalosti:: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100) i rijetko (≥1/10 000 i 1/1000).
English: If you are currently using an oral contraceptive or using a patch contraceptive to prevent pregnancy, you should use an additional or different type of contraception (e.g. condom)
Croatian: Ako trenutno uzimate oralni kontraceptiv ili kontracepcijski flaster za sprječavanje trudnoće, morate koristiti i dodatnu kontracepciju ili neki drugi oblik kontracepcije (npr. prezervativ).
English: EVOTAZ contains two active substances: atazanavir, an antiviral (or antiretroviral) medicine.
Croatian: EVOTAZ sadrži dvije djelatne tvari: atazanavir, antivirusni (ili antiretrovirusni) lijek.
English: Interactions between EVOTAZ and other medicinal products are listed in Table 1 below (increase is indicated as “↑”, decrease as “↓”, no change as “↔”).
Croatian: Interakcije između lijeka EVOTAZ i drugih lijekova navedene su u nastavku, u Tablici 1 (povišenje je označeno kao “↑”, sniženje kao “↓”, bez promjene kao “↔”).
English: The recommended adult dose of EVOTAZ is one tablet daily by mouth and with food, in combination with other anti-HIV medicines.
Croatian: Preporučena doza lijeka EVOTAZ za odrasle je jedna tableta na dan kroz usta, koja se uzima s hranom i u kombinaciji s drugim lijekovima za liječenje HIV infekcije.
English: The mechanism of this decrease is unknown (see sections 4.2 and 4.4.)
Croatian: Mehanizam tog smanjenja nije poznat (vidjeti dijelove 4.2 i 4.4.)
English: Very common (may affect more than 1 in 10 people) ocular icterus (presence of jaundice in the white part of the eyes, i.e. the eyes become yellow) nausea jaundice (when the skin and/or eyes become yellow)
Croatian: Vrlo često (mogu se javiti u više od 1 na 10 osoba) očni ikterus (žutica na bjeloočnicama, tj. oči postaju žute) mučnina žutica (kada koža i/ili oči postaju žuti)
English: A causal relationship has been suggested, although the mechanism of action has not been elucidated.
Croatian: Smatra se da postoji uzročna povezanost, iako mehanizam djelovanja nije razjašnjen.
English: The pharmacokinetics of atazanavir and cobicistat, alone or in combination, have not been evaluated in an elderly population (65 years of age and older).
Croatian: Farmakokinetika atazanavira i kobicistata, primijenjenih samostalno ili u kombinaciji, nije ispitivana u populaciji starijih osoba (u dobi od 65 ili više godina).
English: It is not known whether atazanavir administered to the mother during pregnancy will exacerbate physiological hyperbilirubinaemia and lead to kernicterus in neonates and infants.
Croatian: Nije poznato hoće li atazanavir primijenjen majci tijekom trudnoće pogoršati fiziološku hiperbilirubinemiju i dovesti do kernikterusa u novorođenčadi i dojenčadi.
English: Desacetyl-diltiazem AUC ↑165%
Croatian: Desacetil-diltiazem AUC ↑165%
English: These are listed under Do not take EVOTAZ, at the start of section 2.
Croatian: Ti su lijekovi navedeni u odlomku 'Nemojte uzimati EVOTAZ' na početku dijela 2.
English: Desacetyl-diltiazem Cmax ↑172%
Croatian: Desacetil-diltiazem Cmax ↑172%
English: ERECTILE DYSFUNCTION
Croatian: EREKTILNA DISFUNKCIJA
English: EVOTAZ should not be used in children less than 3 months of age because of safety concerns especially taking into account the potential risk of kernicterus associated with the atazanavir component.
Croatian: EVOTAZ se ne smije primjenjivati u djece mlađe od 3 mjeseca zbog sigurnosnih razloga, osobito kada se u obzir uzme mogući rizik od kernikterusa povezan s primjenom atazanavira.
English: Based on data for other CYP3A4 inhibitors, plasma concentrations of midazolam are expected to be significantly higher when midazolam is given orally.
Croatian: Na temelju podataka za druge inhibitore CYP3A4, očekuje se da će plazmatske koncentracije midazolama biti značajno više kada se midazolam daje peroralno.
English: The 24-hour atazanavir concentration following a high-fat meal was increased approximately 23% due to delayed absorption; the median Tmax increased from 2.0 to 3.5 hours.
Croatian: 24-satna koncentracija atazanavira nakon obroka s visokim udjelom masnoća povisila se za približno 23% zbog odgođene apsorpcije; medijan Tmax produljio se s 2,0 na 3,5 sati.
English: Serum cholesterol and glucose were minimally to mildly increased in rats but not in mice or dogs.
Croatian: Kolesterol i glukoza u serumu bili su minimalno do blago povišeni u štakora, ali ne i u miševa ili pasa.
English: The dose of the H2-receptor antagonist should not exceed a dose comparable to famotidine 20 mg twice daily.
Croatian: Doza antagonista H2receptora ne smije biti veća od doze usporedive s 20 mg famotidina dvaput na dan.
English: ALPHA 1-ADRENORECEPTOR ANTAGONIST Alfuzosin
Croatian: ANTAGONIST ALFA-1 ADRENORECEPTORA Alfuzosin
English: Although this study presented some limitations (i.e., unbound drug concentrations not studied), results suggested that the atazanavir pharmacokinetic parameters were decreased by 30% to 50% in patients undergoing haemodialysis compared to patients with normal renal function.
Croatian: Iako je ovo ispitivanje imalo neka ograničenja (tj. nisu se ispitivale koncentracije nevezanog lijeka), rezultati su pokazali da su se farmakokinetički parametri atazanavira smanjili za 30% do 50% u bolesnika na hemodijalizi u usporedbi s bolesnicima s normalnom funkcijom bubrega.
English: The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease.
Croatian: Trajanje kombinirane antiretrovirusne terapije, primjena kortikosteroida, konzumiranje alkohola, teška imunosupresija i povišen indeks tjelesne mase mogu, između ostaloga, biti neki od mnogih čimbenika rizika za razvoj ove bolesti.
English: Co-administration of EVOTAZ and rilpivirine can be used without dose adjustments, as the expected increase in rilpivirine concentrations is not considered clinically relevant.
Croatian: EVOTAZ i rilpivirin mogu se istodobno primjenjivati bez prilagođavanja doze jer se očekivani porast koncentracija rilpivirina ne smatra klinički značajnim.
English: The use of EVOTAZ in children and adolescents has not yet been studied.
Croatian: Primjena lijeka EVOTAZ u djece i adolescenata nije još ispitana.
English: Study conducted in HIV infected patients
Croatian: Ispitivanje provedeno u bolesnika s HIV infekcijom
English: d Includes patients who discontinued due to adverse event (AE) or death at any time point from day 1 through the time window if this resulted in no virologic data on treatment during the specified window.
Croatian: d Uključuje bolesnike koji su prekinuli liječenje zbog nuspojave ili smrti u bilo kojem trenutku od 1. dana do završetka vremenskog okvira ako zbog toga nije bilo viroloških podataka o liječenju tijekom određenog vremenskog okvira.
English: In GS-US-216-0114, 3.6% of subjects were hepatitis B virus surface antigen positive and 5.3% were hepatitis C virus seropositive.
Croatian: U ispitivanju GS-US-216-0114, 3,6% ispitanika imalo je pozitivan nalaz na površinski antigen virusa hepatitisa B, dok ih je 5,3% bilo seropozitivno na virus hepatitisa C.
English: Subsequent 9 month oral toxicity studies in dogs showed no drug-related electrocardiographic changes.
Croatian: Daljnja 9-mjesečna ispitivanja toksičnosti peroralne primjene u pasa u nisu pokazala elektrokardiografske promjene povezane s lijekom.
English: Similar concentrations of atazanavir increased by 13% the action potential duration (APD90) in rabbit Purkinje fibres study.
Croatian: Slične koncentracije atazanavira produljile su trajanje akcijskog potencijala (APD90) za 13% u ispitivanju na Purkinjeovim vlaknima kunića.
English: Therapy should be initiated by a physician experienced in the management of HIV infection.
Croatian: Terapiju treba započeti liječnik s iskustvom u liječenju HIV infekcije.
English: The mechanism of interaction between atazanavir and tenofovir DF is unknown.
Croatian: Mehanizam interakcije između atazanavira i tenofovira DF nije poznat.
English: A coagulation test helps to identify patients with an increased bleeding risk due to increased dabigatran exposure.
Croatian: Test koagulacije pomaže identificirati bolesnike koji imaju povećan rizik od krvarenja zbog povećane izloženosti dabigatranu.
English: Endothelin Receptor Antagonists
Croatian: Antagonisti endotelinskih receptora
English: ANNEX II A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE LIJEKA U PROMET B. UVJETI ILI OGRANIČENJA VEZANI UZ OPSKRBU I PRIMJENU C. OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET D. UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU
English: No virologic data in week 48 or week 144 window Discontinued study drug due to AE or deathd
Croatian: Bez viroloških podataka u okviru 48. ili 144. tjedna Prekid primjene ispitivanog lijeka zbog nuspojave ili smrtid
English: The safety and efficacy of atazanavir have not been established in patients with significant underlying liver disorders.
Croatian: Sigurnost i djelotvornost atazanavira nisu ustanovljene u bolesnika sa značajnim podležećim jetrenim poremećajima.
English: Patients should be advised to seek medical advice if they experience joint aches and pain, joint stiffness or difficulty in movement.
Croatian: Bolesnicima treba preporučiti da potraže liječnički savjet ako osjete bolove ili ukočenost u zglobovima ili ako se otežano kreću.
English: If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately to seek necessary treatment.
Croatian: Ako primijetite bilo koji simptom infekcije ili druge simptome kao su mišićna slabost, slabost koja počinje u rukama i nogama i širi se prema trupu, osjećaj lupanja srca, nevoljno drhtanje ili hiperaktivnost, odmah o tome obavijestite svog liječnika i zatražite potrebno liječenje.
English: Subsequently, the marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Croatian: Slijedom navedenog, nositelj odobrenja će periodična izvješća o neškodljivosti podnositi u skladu s referentnim popisom datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7. Direktive 2001/83/EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
English: Fluvastatin is partially metabolised by CYP2C9.
Croatian: Fluvastatin se djelomično metabolizira putem CYP2C9.
English: H2-Receptor antagonists
Croatian: Antagonisti receptora H2
English: In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products.
Croatian: U slučaju istodobne antivirusne terapije za liječenje hepatitisa B ili C, pročitajte i odgovarajuće Sažetke opisa svojstava lijeka za te lijekove.
English: Dose titration of the calcium channel blockers should be considered.
Croatian: Treba razmotriti titraciju doze blokatora kalcijevih kanala.
English: Complex or unknown mechanisms of drug interaction preclude extrapolation of ritonavir drug interactions to certain cobicistat drug interactions.
Croatian: Složeni ili nepoznati mehanizmi interakcija između lijekova onemogućuju ekstrapolaciju podataka o interakcijama ritonavira s drugim lijekovima na određene interakcije između kobicistata i drugih lijekova.
English: Desacetyl-diltiazem Cmin ↑121%
Croatian: Desacetil-diltiazem Cmin ↑121%
English: The European Medicines Agency has deferred the obligation to submit the results of studies with EVOTAZ in the treatment of HIV-1 infection (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove odgodila je obvezu podnošenja rezultata ispitivanja lijeka EVOTAZ u liječenju HIV-1 infekcije (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Treatment outcomes at weeks 48 and 144 for study GS-US-216-0114 are presented in Table 3.
Croatian: Ishodi liječenja u 48. i 144. tjednu ispitivanja GS-US-216-0114 prikazani su u Tablici 3.
English: Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Croatian: Od zdravstvenih radnika se traži da prijave svaku sumnju na nuspojavu lijeka putem nacionalnog sustava prijave nuspojava navedenog: u Dodatku V.
English: Electrocardiographic changes (sinus bradycardia, prolongation of PR interval, prolongation of QT interval, and prolongation of QRS complex) were observed only in an initial 2 week oral toxicity study performed in dogs.
Croatian: Elektrokardiografske promjene (sinusna bradikardija, produljenje PR intervala, produljenje QT-intervala i produljenje QRS kompleksa) bile su opažene samo u početnom 2-tjednom ispitivanju toksičnosti peroralne primjene provedenom u pasa.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON TEXT AND BOTTLE LABEL 1.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU TEKST NA KUTIJI I NALJEPNICI BOCE
English: The percentage of subjects with baseline viral loads >100,000 copies/ml was 39.7%.
Croatian: Postotak ispitanika s početnim virusnim opterećenjem od > 100 000 kopija/ml iznosio je 39,7%.
English: PHARMACEUTICAL FORM AND CONTENTS 30 film-coated tablets.
Croatian: 4. FARMACEUTSKI OBLIK I SADRŽAJ 30 filmom obloženih tableta.
English: ERGOT DERIVATES
Croatian: DERIVATI ERGOTA
English: Randomisation was stratified by screening HIV-1 RNA level (≤100,000 copies/ml or >100,000 copies/ml).
Croatian: Randomizacija je bila stratificirana prema rezultatima probira na razinu HIV-1 RNK (≤ 100 000 kopija/ml ili > 100 000 kopija/ml).
English: Cobicistat has no antiviral activity.
Croatian: Kobicistat nema antivirusnu aktivnost.
English: PDE5 Inhibitors
Croatian: Inhibitori PDE5
English: PDE5 inhibitors used for the treatment of erectile dysfunction
Croatian: Inhibitori PDE5 koji se primjenjuju za liječenje erektilne disfunkcije
English: EVOTAZ film-coated tablets are supplied in bottles of 30 tablets.
Croatian: EVOTAZ filmom obložene tablete dolaze u bocama s 30 tableta.
English: Patients with previous liver dysfunction or patients with chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice.
Croatian: Bolesnici s prijašnjom disfunkcijom jetre ili kroničnim aktivnim hepatitisom imaju povećanu učestalost poremećaja funkcije jetre tijekom kombinirane antiretrovirusne terapije i trebaju biti pod nadzorom sukladno standardnoj praksi.
English: Particular caution should be used when prescribing PDE5-inhibitors (sildenafil, tadalafil, vardenafil, or avanafil) for the treatment of erectile dysfunction in patients receiving EVOTAZ.
Croatian: Potreban je osobit oprez kada se inhibitori PDE5 (sildenafil, tadalafil, vardenafil ili avanafil) propisuju za liječenje erektilne disfunkcije u bolesnika koji primaju EVOTAZ.
English: An increase from baseline in serum creatinine solely due to cobicistat's inhibitory effect generally does not exceed 0.4 mg/dl.
Croatian: Povećanje razine serumskog kreatinina u odnosu na početnu vrijednost isključivo zbog inhibitornog učinka kobicistata obično ne premašuje 0,4 mg/dl.
English: EVOTAZ and dolutegravir can be used without dose adjustments.
Croatian: EVOTAZ i dolutegravir mogu se primjenjivati bez prilagođavanja doze.
English: Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
Croatian: Neki bolesnici koji uzimaju kombiniranu antiretrovirusnu terapiju mogu razviti bolest kostiju koja se zove osteonekroza (odumiranje koštanog tkiva zbog prekida opskrbe kosti krvlju).
English: Missing data during window but on study drug a Week 48 window is between day 309 and 378 (inclusive)
Croatian: Nedostaju podaci u tom vremenskom okviru, ali ispitanik je primao ispitivani lijek a Okvir 48. tjedna obuhvaća razdoblje između 309. i 378. dana (uključujući i te dane)
English: Amlodipine Felodipine Nicardipine Nifedipine Verapamil
Croatian: Amlodipin Felodipin Nikardipin Nifedipin Verapamil
English: Potential for increased alfuzosin concentrations which can result in hypotension.
Croatian: Moguće su povišene koncentracije alfuzosina, koje mogu uzrokovati hipotenziju.
English: Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Croatian: Unutar svake skupine učestalosti, nuspojave su navedene u padajućem nizu prema ozbiljnosti.